Your browser doesn't support javascript.
loading
Camrelizumab combined with apatinib in the treatment of patients with hepatocellular carcinoma: a real-world assessment.
Chen, Dongbo; Chen, Xiangxun; Xu, Lei; Wang, Yichun; Zhu, Liyang; Kang, Mei.
Afiliación
  • Chen D; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Chen X; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Xu L; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Wang Y; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Zhu L; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Kang M; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Neoplasma ; 70(4): 580-587, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37789782
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans Idioma: En Revista: Neoplasma Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans Idioma: En Revista: Neoplasma Año: 2023 Tipo del documento: Article País de afiliación: China